CompoAtlas

PROSTAMĪNS vīrieša veselības komplekss

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000607/2016
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
MEDPRO NUTRACEUTICALS SIA
Manufacturer
Francijā pēc SIA
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 kapsulas dienā ēšanas laikā
Published pack size
Kapsula pa 0,333 g
Published packaging
Iepakojumā 60 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
E VITAMĪNSvitamins ; E VITAMĪNS ; 10 ; mg α-TEVitamine EVitamin or mineral
Cinksminerals ; Cinks ; 12 ; mgZincVitamin or mineral
Varšminerals ; Varš ; 1000 ; μgCuivreVitamin or mineral
Pigejas mizas ekstraktsplants ; Pigejas mizas ekstrakts ; Pygeum Africanum ; 2,5 ; mgNot recognisedRole not identified
Parastā ķirbja sēklu ekstraktsplants ; Parastā ķirbja sēklu ekstrakts ; Cucurbita pepo ; 20 ; mgcucurbita pepoPlant
Smalkzāģzobainās sabalpalmas ogu ekstraktsplants ; Smalkzāģzobainās sabalpalmas ogu ekstrakts ; Serenoa repens ; 40 ; mgserenoa repensPlant
Silīcija dioksīds (E 551)otherIngredients ; Silīcija dioksīds (E 551)Listed as food additive E 551 (EU Union list)Role not identified
ŽelatīnsotherIngredients ; ŽelatīnsNot recognisedRole not identified
Taukskābju magnija sāļi (E470b)otherIngredients ; Taukskābju magnija sāļi (E470b)Listed as food additive E 470b (EU Union list)Role not identified
CieteotherIngredients ; CieteNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Smalkzāģzobainās sabalpalmas ogu ekstrakts
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PROSTAMĪNS vīrieša veselības komplekss”, https://compoatlas.com/en/supplements/latvia/5900-prostamins-viriesa-veselibas-komplekss, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line